Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center Identifier:
First received: February 12, 2013
Last updated: March 18, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)